Myocardial Ischemia  >>  Tekturna (aliskiren)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
NCT00414609 / 2006-001704-37: Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)

Completed
3
820
US, Canada, Europe, RoW
Aliskiren, Tekturna®, placebo
Novartis
Myocardial Infarction
09/09
07/11
AQUARiUS, NCT00853827 / 2008-006447-40: Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Completed
3
613
US, Canada, Europe, RoW
Placebo, Aliskiren
Novartis Pharmaceuticals, The Cleveland Clinic
Coronary Artery Disease (CAD), Coronary Atherosclerosis
01/13
01/13

Download Options